The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Does thrombophilia testing help in the clinical management of patients?
Abstract
Summary: Thrombophilia can be identified in about half of all patients presenting with venous thrombosis. Testing has increased tremendously for various indications, but whether the results of such tests help in the clinical management of patients has not been settled. Here, we review the most commonly tested thrombophilic abnormalities, i.e. protein C, protein S, and antithrombin deficiencies, the F5 R506Q (factor V Leiden) and F2 G20210A (prothrombin G20210A) mutations, and elevated levels of coagulation factor VIII, and their association with venous and arterial thrombosis as well as pregnancy complications. We conclude that testing for hereditary thrombophilia generally does not alter the clinical management of patients with venous or arterial thrombosis or pregnancy complications. Because testing for thrombophilia only serves limited purpose this should not be performed on a routine basis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
MIYAKIS, S., LOCKSHIN, M. D., ATSUMI, T., BRANCH, D. W., BREY, R. L., CERVERA, R., DERKSEN, R. H. W. M., DE GROOT, P. G., KOIKE, T., MERONI, P. L., et al. (2006) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2006.01753.x · Cited by 7,203
The management of thrombosis in the antiphospholipid-antibody syndrome
Khamashta, M. A., Cuadrado, M. J., Mujic, F., Taub, N. A., Hunt, B. J., & Hughes, G. R. V. (1995) · New England Journal of Medicine · doi:10.1056/nejm199504133321504 · Cited by 1,450
Antithrombotic Therapy for Venous Thromboembolic Disease
Büller, H. R., Agnelli, G., Hull, R. D., Hyers, T. M., Prins, M. H., & Raskob, G. E. (2004) · Chest · doi:10.1378/chest.126.3_suppl.401s · Cited by 1,249 · cited 2×
“…venous thrombosis After a first episode of venous thrombosis, 3–6 months of anticoagulant therapy is considered to have the optimal balance between the risk of treatment, i.e. bleeding, and the benefit, i.e. the prevention of an extension or recurrence of venous thrombosis (Buller et al, 2004).”
BackgroundRai, R., & Regan, L. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69204-0 · Cited by 1,227
Koster, T., Vandenbroucke, J. P., Rosendaal, F. R., Briët, E., Rosendaal, F. R., & Blann, A. D. (1995) · The Lancet · doi:10.1016/s0140-6736(95)90166-3 · Cited by 1,131 · cited 6×
“In the Leiden Thrombophilia study, a large population-based case–control study on risk factors for venous thrombosis, no increased risk could be demonstrated (Koster et al, 1995a).”
BackgroundInfluentialVandenbroucke, J. P., Koster, T., Rosendaal, F. R., Briët, E., Reitsma, P. H., & Bertina, R. M. (1994) · The Lancet · doi:10.1016/s0140-6736(94)90286-0 · Cited by 1,063
Galli, M., Luciani, D., Bertolini, G., & Barbui, T. (2003) · Blood · doi:10.1182/blood-2002-02-0441 · Cited by 972 · cited 1×
“The presence of antibodies to anticardiolipin, b2-Glycoprotein I, and prothrombin have been associated with thrombosis in some, but not all, studies (Galli et al, 2003; Galli & Barbui, 2005).”
BackgroundCrowther, M. A., Ginsberg, J. S., Julian, J., Denburg, J., Hirsh, J., Douketis, J., Laskin, C., Fortin, P., Anderson, D., Kearon, C., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa035241 · Cited by 919
High plasma levels of factor VIII and the risk of recurrent venous thromboembolism
Kyrle, P. A., Minar, E., Hirschl, M., Bialonczyk, C., Stain, M., Schneider, B., Weltermann, A., Speiser, W., Lechner, K., & Eichinger, S. (2000) · New England Journal of Medicine · doi:10.1056/nejm200008173430702 · Cited by 763 · cited 1×
“Elevated levels of factor VIII and IX have been associated with an increased risk of recurrence in single studies (Kyrle et al, 2000; Weltermann et al, 2003).”
BackgroundKearon, C., Ginsberg, J. S., Kovacs, M. J., Anderson, D. R., Wells, P., Julian, J. A., MacKinnon, B., Weitz, J. I., Crowther, M. A., Dolan, S., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa035422 · Cited by 751
Cited by
EASL Clinical Practice Guidelines: Vascular diseases of the liver
(2016) · Journal of Hepatology · doi:10.1016/j.jhep.2015.07.040 · Cited by 808
Clinical guidelines for testing for heritable thrombophilia
Baglin, T., Gray, E., Greaves, M., Hunt, B. J., Keeling, D., Machin, S., Mackie, I., Makris, M., Nokes, T., Perry, D., et al. (2010) · British Journal of Haematology · doi:10.1111/j.1365-2141.2009.08022.x · Cited by 499
Guidance for the treatment and prevention of obstetric-associated venous thromboembolism
Bates, S. M., Middeldorp, S., Rodger, M., James, A. H., & Greer, I. (2016) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-015-1309-0 · Cited by 441
Self-citationThrombophilia Testing and Venous Thrombosis
Connors, J. M. (2017) · New England Journal of Medicine · doi:10.1056/nejmra1700365 · Cited by 406
Metadata
- Authors
- Middeldorp, S., & Van Hylckama Vlieg, A.
- Venue
- British Journal of Haematology
- Publisher
- Wiley
- Published
- 2008-10-14
- Volume
- 143
- Issue
- 3
- Pages
- 321-335
- ISSN
- 0007-1048 (ISSN-L)
- 1365-2141
- OpenAlex
- W2000887962
- Cited by
- 177
- References
- 21
- FWCI
- 8.20
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Does thrombophilia testing help in the clinical management of patients? https://app.cochat.ai/papers/10.1111/j.1365-2141.2008.07339.x
- The paper
- Middeldorp, S., & Van Hylckama Vlieg, A. (2008). Does thrombophilia testing help in the clinical management of patients? British Journal of Haematology. https://doi.org/10.1111/j.1365-2141.2008.07339.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.